- Home
- TPST vs GROW Comparison
TPST vs GROW Comparison
Compare TPST & GROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TPST
- GROW
- Stock Information
- Founded
- TPST 2011
- GROW 1968
- Country
- TPST United States
- GROW United States
- Employees
- TPST N/A
- GROW N/A
- Industry
- TPST Biotechnology: Pharmaceutical Preparations
- GROW Investment Managers
- Sector
- TPST Health Care
- GROW Finance
- Exchange
- TPST Nasdaq
- GROW Nasdaq
- Market Cap
- TPST 33.0M
- GROW 31.8M
- IPO Year
- TPST N/A
- GROW N/A
- Fundamental
- Price
- TPST $7.08
- GROW $2.44
- Analyst Decision
- TPST Hold
- GROW
- Analyst Count
- TPST 3
- GROW 0
- Target Price
- TPST $30.00
- GROW N/A
- AVG Volume (30 Days)
- TPST 241.4K
- GROW 46.3K
- Earning Date
- TPST 08-07-2025
- GROW 05-08-2025
- Dividend Yield
- TPST N/A
- GROW 3.69%
- EPS Growth
- TPST N/A
- GROW N/A
- EPS
- TPST N/A
- GROW 0.01
- Revenue
- TPST N/A
- GROW $8,932,000.00
- Revenue This Year
- TPST N/A
- GROW N/A
- Revenue Next Year
- TPST N/A
- GROW N/A
- P/E Ratio
- TPST N/A
- GROW $233.35
- Revenue Growth
- TPST N/A
- GROW N/A
- 52 Week Low
- TPST $5.35
- GROW $2.02
- 52 Week High
- TPST $30.03
- GROW $2.73
- Technical
- Relative Strength Index (RSI)
- TPST 50.32
- GROW 54.36
- Support Level
- TPST $6.73
- GROW $2.42
- Resistance Level
- TPST $7.18
- GROW $2.54
- Average True Range (ATR)
- TPST 0.29
- GROW 0.09
- MACD
- TPST 0.00
- GROW -0.01
- Stochastic Oscillator
- TPST 78.01
- GROW 36.84
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.
About GROW U.S. Global Investors Inc.
US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.